Literature DB >> 7978283

Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry.

H C Yeo1, H J Helbock, D W Chyu, B N Ames.   

Abstract

Malondialdehyde (MDA) is assayed in femtomole quantities in biological samples by gas chromatography-mass spectrometry (GC-MS). The MDA trapped in protein as a Schiff base is released by H2SO4, the protein precipitated using Na2WO4, and the MDA derivatized with pentafluorophenylhydrazine to form the stable adduct, N-pentafluorophenylpyrazole. Negative chemical ionization (NCI) capability allows the sensitive detection of this MDA adduct in biological samples at a level of 5 nM on-column. A stable-isotope-labeled MDA, [2H2]MDA, was used as an internal standard for quantitation. MDA recovery from plasma was 76%. This assay provides two forms of confirmation of the analyte, retention time and mass ion, thus minimizing error due to interfering compounds. The commonly used thiobarbituric acid assay for MDA overestimates the MDA levels by over 10-fold, possibly resulting from cross-reactivity with other aldehydes and artifactual oxidation due to 100 degrees C temperature conditions. In our assay, all steps were performed at room temperature thereby suppressing artifactual oxidation of the sample. We have successfully applied this assay to biological samples including plasma, tissue homogenates, and sperm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978283     DOI: 10.1006/abio.1994.1355

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  18 in total

Review 1.  In vivo measurement of the redox state.

Authors:  D Praticò
Journal:  Lipids       Date:  2001       Impact factor: 1.880

2.  Modifications of proteins by polyunsaturated fatty acid peroxidation products.

Authors:  H H Refsgaard; L Tsai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

4.  Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved.

Authors:  B Paquette; P K Fortier; J Héroux; P A Thibodeau; R Wagner; J Liu; A Cantin
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

5.  Inducible malondialdehyde pools in zones of cell proliferation and developing tissues in Arabidopsis.

Authors:  Emanuel Schmid-Siegert; Jorge Loscos; Edward E Farmer
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

6.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Authors:  Milton Hamblin; David B Friedman; Salisha Hill; Richard M Caprioli; Holly M Smith; Michael F Hill
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

7.  Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism.

Authors:  David V Folden; Akanksha Gupta; Avadhesh C Sharma; Shi-Yan Li; Jack T Saari; Jun Ren
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Biomarkers of oxidative stress study V: ozone exposure of rats and its effect on lipids, proteins, and DNA in plasma and urine.

Authors:  Maria B Kadiiska; Samar Basu; Nathan Brot; Christopher Cooper; A Saari Csallany; Michael J Davies; Magdalene M George; Dennis M Murray; L Jackson Roberts; Mark K Shigenaga; Rajindar S Sohal; Roland Stocker; David H Van Thiel; Ingrid Wiswedel; Gary E Hatch; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2013-04-19       Impact factor: 7.376

9.  Membranes as Structural Antioxidants: RECYCLING OF MALONDIALDEHYDE TO ITS SOURCE IN OXIDATION-SENSITIVE CHLOROPLAST FATTY ACIDS.

Authors:  Emanuel Schmid-Siegert; Olga Stepushenko; Gaetan Glauser; Edward E Farmer
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.